Nurden, Alan T.

Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice

Deppermann, C., Cherpokova, D., Nurden, P., Schulz, J.-N., Thielmann, I., Kraft, P., Vögtle, T., Kleinschnitz, C., Dütting, S., Krohne, G., et al. (2013) · Journal of Clinical Investigation

Platelet Disorders and TreatmentsBlood Coagulation and Thrombosis Mechanisms

Cited by 200

Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities

Anitua, E., Sanchez, M., Nurden, A. T., Zalduendo, M., de la Fuente, M., Orive, G., Azofra, J., & Andia, I. (2006) · Journal of Biomedical Materials Research Part A

Tendon Structure and TreatmentPeriodontal Regeneration and Treatments

Cited by 188

Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A

Du, L. M., Nurden, P., Nurden, A. T., Nichols, T. C., Bellinger, D. A., Jensen, E. S., Haberichter, S. L., Merricks, E., Raymer, R. A., Fang, J., et al. (2013) · Nature Communications

Hemophilia Treatment and ResearchPlatelet Disorders and Treatments

Cited by 119